Why Did Katrine Bosley Step Down?
On Twitter, Bosley Called Her Decision to Step Down a Tough One. She Said She Believes in the Mission of Repairing Broken Genes to Treat Various Diseases. She...
On Twitter, Bosley called her decision to step down a tough one. She said she believes in the mission of repairing broken genes to treat various diseases. She wished her colleagues success on the “really important mission.” ... EDIT-101 is a therapy for Leber Congenital Amaurosis (LCA) 10, an inherited retinal disorder.
Why did Editas CEO resign?
One chief medical officer came and went in the roughly 18 months Collins has been CEO. Most recently, Charles Albright, Editas' chief scientific officer since August 2016, left in mid-January to "pursue another opportunity." A search for his replacement remains ongoing, a company spokesperson confirmed Monday.
Who founded Editas medicine?
Keith Joung of Harvard University, with funding from Third Rock Ventures, Polaris Partners and Flagship Ventures; the name was changed to the current "Editas Medicine" 2 months later. Doudna quit in June 2014 over legal differences concerning intellectual property of Cas9.
James Sterling reports on renewable energy developments, climate policy, ecological conservation, and green tech innovations around the globe.
